Hoxton Ventures is an early-stage, deliberately anti-thematic venture capital firm that backs ambitious European founders aiming to build category-defining global winners. They focus on pre-seed and seed-stage startups, actively helping them scale and expand into the U.S. market early in their lifecycle.
About Hoxton Ventures
Hoxton Ventures is a London-based seed fund led by Hussein Kanji and Rob Kniaz, best known for early checks into Deliveroo, Babylon Health, and Darktrace, with a thesis built around generalist seed investing in European founders pursuing global category leadership. Hoxton typically writes $1M to $5M initial checks at seed or pre-seed, leads or co-leads, and reserves significant follow-on capital. Healthcare exposure is partial; Babylon Health was a marquee win and the fund will look at health and bio software where the team and market are exceptional, but healthcare is not a dedicated vertical. AI focus is current and credible across the portfolio. Founders best suited are European, especially UK-based, technical founders building global software companies in any vertical including healthcare, who want a hands-on seed lead with US fund relationships for follow-on rounds. Founders who do not fit include US-headquartered teams, therapeutics, devices, and capital-intensive businesses. The entry path is warm introduction through a portfolio CEO, particularly Babylon alumni, or a London angel with a relationship to the partners. LinkedIn outreach to Hussein Kanji is well-publicized as acceptable provided the message is short, concrete, and shows traction or a unique insight. Expect a fast first meeting, a candid second meeting, and a fund that will lead at seed but expects founders to drive the round.
Founder reviews
Healthcare AI tools backed by Hoxton Ventures
Tools made by companies in Hoxton Ventures's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Hoxton Ventures's portfolio not currently in our directory.
- Babylon Health · 2015
- BioCorteX · 2022
- Baseimmune · 2021
- biotx.ai
- Multiomic Health
- Phagos · 2022
- Panakeia
Team
Pitch / review this investor
Have you raised from Hoxton Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).